Quicoy, Acelyn .
HRN: 25-71-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/19/2024
08/26/2024
IV
35mg
Q24
Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaBloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes